Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

CHC Healthcare Group: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

12 Apr 2014 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - CHC HEALTHCARE GROUP (4164-TW)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

15 Apr 2014 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for CHC Healthcare Group

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

15 Apr 2014 Wright Reports 38 $75.00

承業醫(4164):聽見中國好聲音

投資建議買進:元富預估2013年EPS 2.79元,2014年考量中國市場放射腫瘤治療機銷售不確定性較大,以及租賃合約通常6~12月後才有顯著貢獻,目前2014年中國營收獲利貢獻預估值僅包含1H14可望認列之一台直線加速器,稅後EPS即達3.82元,...

15 Nov 2013 MasterLink Securities Corporation 2 $23.00

CHC Healthcare Group (4164 TT): To Enjoy Long-term Growth Momentum

CHC announced distribution of IBA’s proton therapy equipment; its first client is Changhua Christian Hospital (CCH). If CHC s...

01 Nov 2012 MasterLink Securities Corporation 4 $35.00

承業(4164):長期獲利動能佳

承業近期已與全球最大質子治療設備大廠IBA簽約代理,首家合作醫院為彰化基督教醫院。元富推估,若以賣斷模式銷售,2012年底前將可認列第一筆頭期款約2.4億元,將貢獻EPS 0.2元。承業取得IBA代理權後,目前國內已有多家醫院正積極洽談中,目前公司推...

29 Oct 2012 MasterLink Securities Corporation 3 $12.00

台灣今日精選圖表:生技大趨勢

醫療服務公司承業生醫(4164.TW)掛牌上市:承業生醫成立於2009年,前身為久和儀器,主要從事放射腫瘤、神經科學、影像醫學、核子醫學、牙科及眼科之儀器設備銷售、租賃及維護等業務,其中又以放射腫瘤設備之銷售、設備投放合作收入及勞務收入佔2011年營...

19 Oct 2012 KGI Greater China 2 $23.00